Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Carboplatin 8Paclitaxel 7Taxes 6Cisplatin 6pembrolizumab 5Surgical Procedures, Operative 4Radiotherapy, Intensity-Modulated 4Platinum 4Fluorouracil 4Capecitabine 41,2-diaminocyclohexaneplatinum II citrate 4Radiotherapy, Conformal 3Metformin 3Etoposide 3Doxorubicin 3Cyclophosphamide 3Brachytherapy 3folfirinox 2aumolertinib 2Radiotherapy 2Proton Therapy 2Prednisone 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leucovorin 2Ifosfamide 2Gemcitabine 2Folfox protocol 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Has results × treosulfan × Clear all
NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Unknown
102 enrolled 12 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡